centre

The telecommunications company Cronos Group, based in Hong Kong, is opening its European offices in Barcelona to offer services throughout the continent and worlwide. According to the Catalan Ministry of Business and Employment, the company is expected to create 25 new jobs in the first year operating from the Catalan capital. Currently 10 people are already working in Cronos’ Barcelona offices. The project received the assistance of the Catalan Government’s programme ‘Invest in Catalonia’, which focuses on attracting foreign investment and international business. Cronos’s Managers explained they have decided to settle in Barcelona because it had become the world capital of the mobile phone and of telecommunications, since each year it organises the main international event in this sector. Furthermore, Cronos Group praised the talent and skills of Catalan workers.

Researchers from Barcelona’s Centre for Regenerative Medicine (CMRB), the Catalan capital’s Hospital Clínic and the Salk Institute of California have successfully created three-dimensional renal structures which are virtually indistinguishable from embryonic kidneys. They have started creating kidney cells from human stem cells, and ultimately proven that these newly created cells could aggregate in vitro to form a “micro-kidney”. The team led by Juan Carlos Izpisúa, from the CMRB, said that this scientific breakthrough would facilitate the study of kidney diseases and enable scientists to work on new treatments. He added that this achievement was a great step towards developing therapies based on the use of stem cells.

The University of Lleida (Western Catalonia) will be leading the INNOSTORAGE Project regarding efficient thermal storage. They will focus their study on improving energy-storing by using Phase Change Materials and their temperature changes. The project, which is financed by the European Commission, aims at reducing CO2 emissions and saving energy by finding new efficient energy-storing systems. Thanks to the Marie Curie International Research Staff Exchange Scheme (IRSES), INNOSTORAGE brings together searchers from Catalonia, France, Israel, the United-States, Australia, and New-Zealand.

Researchers of Barcelona-based Vall d’Hebron Hospital and Research Institute discovered some of the main causes of the Idiopathic Pulmonary Fibrosis, which were unknown before today. Vall d’Hebron’s study showed that a continuous exposure to feather pillows and duvets was one of the main causes of this illness as it favours the scarring of lung tissue. This disease provokes a progressive decline of lung function and leads to asphyxia because of the deterioration of the organ’s tissue. The study has been able to trace the diseases’ causes in half of the studied cases. Besides feather pillows and duvets, the persistent exposure to fungus and close contact with birds can also trigger the illness. The Catalan research allows for a new approach to the illness’ prevention and its diagnosis in the early stages. It also represents a completely new approach to this pathology in terms of treatment.

At the HIV Vaccine World Congress, which is taking place in Barcelona between the 7^th and 10^th October, Catalan researchers presented a vaccine prototype that has proven to be effective in clinical studies conducted with mice and monkeys. The vaccine stimulates the creation of antibodies and attacks infected cells. The prototype has been created by the Catalan programme to develop a vaccine against HIV, HIVACAT. According to the programme’s Scientific Director, Christian Brander, the vaccine could eventually also be used as a therapeutic treatment.

The founder and CEO of technology company GFT announced that they will create 500 new jobs in Catalonia in the coming years. In an exclusive interview with the CNA, Ulrich Dietz, stated that he has “aggressive plans to increase the staff” in Greater Barcelona and Lleida. GFT  specialises in developing technological solutions for the banking and insurance sectors, with a turnover of €231 million in 2012. With several offices in Germany, the company is based in Stuttgart and is present in Brazil, France, Italy, Switzerland, Spain, US and UK. A quarter of GFT employees throughout the world are based in Catalonia. Most of them work in Greater Barcelona, which is the company’s “hub” for the European market. Dietz explained that he has plans to develop Lleida’s facilities, which currently employ 40 people, “significantly”.

According to a medical study developed in Barcelona’s Hospital Clínic, fetuses conceived by assisted reproduction have changes in their heart and arteries, which begin even before birth and persist in the postnatal period. These changes represent a significant increase in cardiovascular risk in adulthood. However, the researchers point out that this situation is reversible from the beginning of life through a diet rich in omega3 and other factors. In addition, they strongly emphasised that this is only a risk factor and not a disease. The study leader, Eduard Gratacós, said that “it's a message of opportunity, not alarm”. Furthermore, they also recommend monitoring the blood pressure of these babies.

Barcelona has unveiled a new museum located in the Born neighbourhood, next to the Gothic quarter, which explores how life was in the city during the early 18^th century, and will exhibit 8,000 objects. The Born Cultural Centre shows the neighbourhood’s ruins dating from 1714, when residents were forced to destroy their own homes and leave without any compensation after Barcelona’s military defeat. Next to the area, the largest urban military citadel in Europe was built, being part of the fierce repression that the Bourbon troops inflicted on Catalan citizens. From that moment onwards, Catalonia lost its self-government institutions, its own laws and freedoms, and Catalan language was banned and persecuted with the aim to homogenise the recently-formed Spain.

The Balfegó Group, which captures wild tuna to breed them and sell them to Japan, has launched a new ecotourism project: scuba diving surrounded by the Atlantic bluefin tuna, the world’s largest tuna species and a food delicacy. The ‘Tuna Diving Tour’ is located in L’Ametlla de Mar, on Catalonia’s Costa Daurada. Visitors sail by catamaran to the Balfegó Group’s giant bluefin tuna cages – situated in the middle of sea –, and then dive amongst 400 tuna, some of which are 2 metres long and weigh 250 kg. Each trip involves 20 visitors and they will receive a tour and learn about the process of catching and farming the endangered Atlantic bluefin tuna. The tour starts at 10 am, lasts two hours, and takes place every Sunday throughout the year.

The Catalan Institute of Photonic Sciences (ICFO), based in Greater Barcelona, is the highest ranked centre in the world in the fields of physics and astronomy, according to a survey carried out by Excellence Mapping. This ranking sorts the world’s leading research centres according to 17 different areas of academia. The ICFO was ranked first in physics and astronomy, while the Catalan Institute for Research and Advanced Studies (ICREA) was placed third in this category. Other Catalonia-based institutions that were included in the list were: the Institute for High Energy Physics, IFAE (18^th place), the Universitat Autònoma of Barcelona (UAB) and the Polytechnic University of Barcelona (UPC). The Director of the ICFO, Lluís Torner, told the CNA that the Catalan model of research is “highly competitive”.

Christian Brander is a researcher at the IrsiCaixa AIDS Research Institute and Scientific Director of HIVACAT, the programme for the development of a HIV vaccine. He graduated from the University of Bern in 1994 with a PhD in Immunology and has spent 13 years at Harvard University focusing on cellular immunity to viral infections.

The Catalan research centre has unveiled a new 625-square-metre space where the Academic Research Organisation (ARO) will be based. The ARO will provide support for clinical trials developed throughout the world regarding quality control, methodological, regulatory, statistical and management aspects. Furthermore, the new space has 7 medical boxes, nursery support and a lab to process the samples, which will provide an integral service for clinical trials. The new facilities will be able to host between 750 and 1,100 patients per year and work on 350 trials. It cost €1.2 million, which came from public funds.

50% of tumours are related to mutations of this gene, according to the researchers. A study developed by the Bellvitge Institute of Biomedical Research (IBIDELL), based in Greater Barcelona, and the University of Cincinnati have discovered the role of the noncoding 5S rRNA molecule. This molecule regulates the P53 Tumour Suppressor Gene, which protects healthy cells from turning into cancerous cells. When the cell functions correctly, the levels of P53 are low and stable, but when something wrong is detected, the levels increase and cause the cell’s death, avoiding the development of a tumour. The director of the study, George Thomas, explained that understanding how the P53 works and regulates itself is extremely important since “more than half of the tumours present mutations of this gene”.

The exposure to music during in vitro fertilisation has a positive impact on the fecundity rate of egg cells according to a study developed by the assisted reproduction centre Institut Marquès, based in Barcelona. The study concludes that the micro vibrations in the music shake the culture liquid in which the ovum swims and this improves the distribution of nutrients and also avoids the accumulation of toxic products. As a result, the fertilisation of the ovum is facilitated and the success rate is improved by 4.8%. Three styles of music were tested (pop, heavy metal and classical) but no significant differences were observed in relation to the different frequencies.

Telefónica’s R&D centre in Barcelona’s 22@ technological district will lead the company’s innovation internationally and will significantly increase its staff numbers, which currently stands at 220 workers. The decision strengthens Barcelona’s position as the Mobile World Capital, as it already hosts the main event of the mobile technology industry at an international level. In total, Telefónica has 6 R&D centres spread throughout the world. Besides Barcelona, the company’s innovation centres are based in Silicon Valley, Sao Paulo, London, Tel Aviv and Madrid. The Barcelona centre is now celebrating its 10th anniversary. In the last decade, Telefónica has invested up to €200 million in its Catalan centre, €28 million of which was in 2012.